Clinical trial NCT01111669 - References

Chronic Rhinosinusitis With Polyposis — Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus Surgery

Citation(s)

•   Carrión-Carrión C, del Pozo-Losada J, Gutierrez-Ramos R, de Lucas-Laguna R, García-Diaz B, Casado-Jiménez M, Esperanza-Jiménez Caballero ME
  Bullous eruption induced by tranexamic acid. Ann Pharmacother. 1994 Nov;28(11):1305-6.
•   Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, Laupacis A, Fergusson D
  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001886. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD001886.
•   Ho KM, Ismail H
  Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care. 2003 Oct;31(5):529-37.
•   Kavanagh GM, Sansom JE, Harrison P, Warwick JA, Peachey RD
  Tranexamic acid (Cyklokapron)-induced fixed-drug eruption. Br J Dermatol. 1993 Feb;128(2):229-30.
•   Kitamura H, Matsui I, Itoh N, Fujii T, Aizawa M, Yamamoto R, Okuno A, Okazaki Y, Fujita Y, Kuwayama Y, Imai E, Fujii M
  Tranexamic acid-induced visual impairment in a hemodialysis patient. Clin Exp Nephrol. 2003 Dec;7(4):311-4.
•   Snir M, Axer-Siegel R, Buckman G, Yassur Y
  Central venous stasis retinopathy following the use of tranexamic acid. Retina. 1990;10(3):181-4.

Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus Surgery: A Double Blind Randomized Controlled Trial

Details for clinical trial NCT01111669